A torn ACL used to mean months on crutches and a long wait for surgery. Increasingly, it means a platelet-rich plasma injection instead — a shift quietly reshaping how orthopedic medicine treats injury, aging, and joint disease. Here's a numbers-first look at the market behind that shift. The Numbers The global orthobiologics market was valued at USD 7.1 billion in 2025. It's projected to...